McKesson Settles 2018 Price Fixing Suit With $141m Payment
Class Of Shareholders Had Alleged Financials ‘Premised On Illegal Activity’
Executive Summary
US distribution giant McKesson has reached a nine-figure settlement deal with shareholders to resolve a class action lawsuit alleging that it participated in a price-fixing and anticompetitive scheme for generic drugs with manufacturers and other wholesalers.